Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 81 results.
User Information
Export Records
  1. 1.   Development of a human papillomavirus (HPV) multiplex immunoassay to profile HPV antibodies
  2. Quang, Chau; Chung, Amy W; Kemp,Troy; Ratu, Tupou; Tuivaga, Evelyn; Russell, Fiona M; Licciardi, Paul V; Toh, Zheng Q
  3. Journal of Medical Virology. 2024, Jun; 96(6): e29732.
  1. 2.   Nonameric structures of the cytoplasmic domain of FlhA and SctV in the context of the full-length protein
  2. Kuhlen, Lucas; Johnson,Steven; Cao, Jerry; Deme,Justin; Lea,Susan
  3. PLOS ONE. 2021, Jun 18; 16(6):
  1. 3.   Ebola virus disease
  2. Jacob, Shevin T.; Crozier,Ian; Fischer, William A.; Hewlett, Angela; Kraft, Colleen S.; de La Vega, Marc-Antoine; Soka, Moses J.; Wahl, Victoria; Griffiths, Anthony; Bollinger, Laura; Kuhn, Jens H.
  3. Nature reviews. Disease primers. 2020, Feb 20; 6(1):
  1. 4.   IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
  2. Starkey, Malcolm R; Plank, Maximilian W; Casolari, Paolo; Papi, Alberto; Pavlidis, Stelios; Guo, Yike; Cameron, Guy J M; Haw, Tatt Jhong; Tam, Anthony; Obiedat, Ma'en; Donovan, Chantal; Hansbro, Nicole G; Nguyen, Duc H; Nair, Prema Mono; Kim, Richard Y; Horvat, Jay C; Kaiko, Gerard E; Durum,Scott; Wark, Peter A; Sin, Don D; Caramori, Gaetano; Adcock, Ian M; Foster, Paul S; Hansbro, Philip M
  3. The European respiratory journal. 2019, JUL 1; 54(1): pii: 1800174..
  1. 5.   Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys
  2. Hammoud, Dima A.; Lentz, Margaret R.; Lara, Abigail; Bohannon, Jordan K.; Feuerstein, Irwin; Huzella, Louis; Jahrling, Peter B.; Lackemeyer, Matthew; Laux, Joseph; Rojas, Oscar; Sayreid, Philip; Solomon,Jeffrey; Cong, Yu; Munster, Vincent; Holbrook, Michael R.
  3. PLoS neglected tropical diseases. 2018, Nov 21; 12(11):
  1. 6.   Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand
  2. Jain, A.; Kovacs, J. A.; Nelson, D. L.; Migueles, S. A.; Pittaluga, S.; Fanslow, W.; Fan, X. Y.; Wong, D. W.; Massey, J.; Hornung, R.; Brown, M. R.; Spinner, J. J.; Liu, S. Y.; Davey, V.; Hill, H. A.; Ochs, H.; Fleisher, T. A.
  3. Blood. 2011, Oct; 118(14): 3811-3817.
  1. 7.   Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives
  2. Kaczmarek, P.; Tocci, G. M.; Keay, S. K.; Adams, K. M.; Zhang, C. O.; Koch, K. R.; Grkovic, D.; Guo, L.; Michejda, C. J.; Barchi, J. J.
  3. Acs Medicinal Chemistry Letters. 2010, Nov; 1(8): 390-394.
  1. 8.   MYH9 Genetic Variants Associated With Glomerular Disease: What Is the Role for Genetic Testing?
  2. Kopp, J. B.; Winkler, C. A.; Nelson, G. W.
  3. Seminars in Nephrology. 2010, Jul; 30(4): 409-417.
  1. 9.   Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
  2. Dowdell, K. C.; Niemela, J. E.; Price, S.; Davis, J.; Hornung, R. L.; Oliveira, J. B.; Puck, J. M.; Jaffe, E. S.; Pittaluga, S.; Cohen, J. I.; Fleisher, T. A.; Rao, V. K.
  3. Blood. 2010, Jun; 115(25): 5164-5169.
  1. 10.   Reverse transcriptase in motion: Conformational dynamics of enzyme-substrate interactions
  2. Gotte, M.; Rausch, J. W.; March, B.; Sarafianos, S.; Le Grice, S. F. J.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2010, May; 1804(5): 1202-1212.
  1. 11.   Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression
  2. Witko, S. E.; Johnson, J. E.; Kalyan, N. K.; Felber, B. K.; Pavlakis, G. N.; Sidhu, M. K.; Hendry, R. M.; Udem, S. A.; Parks, C. L.
  3. Journal of Virological Methods. 2010, Mar; 164(1-2): 43-50.
  1. 12.   Preexisting Infection with Human T-Cell Lymphotropic Virus Type 2 neither Exacerbates nor Attenuates Simian Immunodeficiency Virus SIVmac251 Infection in Macaques
  2. Gordon, S. N.; Weissman, A. R.; Cecchinato, V.; Fenizia, C.; Ma, Z. M.; Lee, T. H.; Zaffiri, L.; Andresen, V.; Parks, R. W.; Jones, K. S.; Heraud, J. M.; Ferrari, M. G.; Chung, H. K.; Venzon, D.; Mahieux, R.; Murphy, E. L.; Jacobson, S.; Miller, C. J.; Ruscetti, F. W.; Franchini, G.
  3. Journal of Virology. 2010, Mar; 84(6): 3043-3058.
  1. 13.   Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
  2. Rao, V. K.; Price, S.; Perkins, K.; Aldridge, P.; Tretler, J.; Davis, J.; Dale, J. K.; Gill, F.; Hartman, K. R.; Stork, L. C.; Gnarra, D. J.; Krishnamurti, L.; Newburger, P. E.; Puck, J.; Fleisher, T.
  3. Pediatric Blood & Cancer. 2009 52(7): 847-852.
  1. 15.   Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis
  2. Rausch, J. W.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2007, Jan; 35(1): 256-268.
  1. 16.   Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection
  2. Si, Z. H.; Vandegraaff, N.; O'HUigin, C.; Song, B.; Yuan, W.; Xu, C.; Perron, M.; Li, X.; Marasco, W. A.; Engelman, A.; Dean, M.; Sodroski, J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, MAY 9; 103(19): 7454-7459.
  1. 17.   Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization
  2. McWilliams, M. J.; Julias, J. G.; Sarafianos, S. G.; Alvord, W. G.; Arnold, E.; Hughes, S. H.
  3. Virology. 2006, May; 348(2): 378-388.
  1. 18.   On the nature of oxoiron (IV) intermediate in dioxygen activation by non-heme enzymes
  2. Nemukhin, A. V.; Topol, I. A.; Cachau, R. E.; Burt, S. K.
  3. Theoretical Chemistry Accounts. 2006, MAY; 115(5): 348-353.
  1. 19.   Examining Ty3 polypurine tract structure and function by nucleoside analog interference
  2. Dash, C.; Marino, J. P.; Le Grice, S. F. J.
  3. Journal of Biological Chemistry. 2006, FEB 3; 281(5): 2773-2783.
  1. 20.   Molecular replacement with pseudosymmetry and model dissimilarity: a case study
  2. Jaskolski, M.; Li, M.; Laco, G.; Gustchina, A.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2006, FEB; 62(Part 2): 208-215.
  1. 21.   Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
  2. Wei, M. H.; Toure, O.; Glenn, G. M.; Pithukpakorn, M.; Neckers, L.; Stolle, C.; Choyke, P.; Grubb, R.; Middelton, L.; Turner, M. L.; Walther, M. M.; Merino, M. J.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, JAN; 43(1): 18-27.
  1. 22.   Comparison of the NO and HNO donating properties of diazeniumdiolates: Primary amine adducts release HNO in vivo
  2. Miranda, K. M.; Katori, T.; de Holding, C. L. T.; Thomas, L.; Ridnour, L. A.; MeLendon, W. J.; Cologna, S. M.; Dutton, A. S.; Champion, H. C.; Mancardi, D.; Tocchetti, C. G.; Saavedra, J. E.; Keefer, L. K.; Houk, K. N.; Fukuto, J. M.; Kass, D. A.; Paolocci, N.; Wink, D. A.
  3. Journal of Medicinal Chemistry. 2005, DEC 29; 48(26): 8220-8228.
  1. 23.   Structure of a V3-containing HIV-1 gp120 core
  2. Huang, C. C.; Tang, M.; Zhang, M. Y.; Majeed, S.; Montabana, E.; Stanfield, R. L.; Dimitrov, D. S.; Korber, B.; Sodroski, J.; Wilson, I. A.; Wyatt, R.; Kwong, P. D.
  3. Science. 2005, NOV 11; 310(5750): 1025-1028.
  1. 24.   Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells
  2. Wallqvist, A.; Huang, R.; Covell, D. G.; Roschke, A. V.; Gelhaus, K. S.; Kirsch, I. R.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1559-1568.
  1. 25.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel